As the US Supreme Court mulls the so-called pay-for-delay schemes of the pharmaceutical industry, major drugstore retail chain Walgreen Co. has reportedly acquired a majority ownership stake of a pharmaceutical wholesaler, giving Walgreens a major upper-hand when negotiating drug prices. Walgreens currently has a supply agreement with AmerisourceBergen Corp. in a 10-year deal. Now, Walgreens will hold a majority stake in the company, while European retailer Alliance Boots will hold a minority stake. The contract allows Walgreens and Boots to buy up to 7 percent of AmerisouceBergen’s shares as well as warrants to pursue another 16 percent. The deal is just a further expansion of Walgreen’s $7 billion investment in global expansion; if Walgreens pursues its ability to purchase another 16 percent in 2015, the chain will have fully acquired AmerisourceBergen. The pharmaceutical wholesaler supplies brand name and generic drugs to Walgreens.
Full Content: Omaha.com
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.

A federal appeals court on Thursday temporarily put on hold a lower court ruling that had delivered a significant victory to government employees and consumer advocates opposing President Donald Trump’s efforts to curtail the Consumer Financial Protection Bureau (CFPB). According to Reuters, the decision maintains a temporary pause while the court considers an emergency request from the Justice Department to overturn the previous ruling entirely.
The U.S. Circuit Court of Appeals for the District of Columbia stopped short of reversing any provisions set forth by U.S. District Judge Amy Berman Jackson in her March 28 ruling. Per Reuters, her decision had ordered the CFPB to reinstate dismissed employees, restore canceled contracts, and continue performing its legally mandated duties. However, the appellate judges left in place interim measures preventing the administration from taking further action against agency staff or halting essential operations.
Despite the temporary stay, the three-judge panel emphasized that the decision should not be interpreted as an indication of their final ruling. “The purpose of this administrative stay is to give the court sufficient opportunity to consider the emergency motion for stay pending appeal and should not be construed in any way as a ruling on the merits of that motion,” the order stated, according to Reuters.
Related: CFPB Allows Some Operations to Resume Amid Legal Challenge
The Justice Department formally notified the court on Saturday of its intent to challenge Judge Berman Jackson’s order, seeking to overturn her directive that prevented the administration from erasing agency data, terminating employees, or discontinuing active contracts. The Trump administration’s moves against the CFPB began in February when the president dismissed the agency’s director and granted officials from Elon Musk’s Department of Government Efficiency extensive access to sensitive CFPB data systems. The actions resulted in widespread layoffs, contract cancellations, and office closures, prompting consumer protection groups and affected workers to file a lawsuit denouncing the changes as unlawful.
According to Reuters, agency leadership has since attempted to walk back some of these measures, a move Judge Berman Jackson described as likely “a charade for the court’s benefit.” While the appeals court’s temporary stay keeps aspects of the lower court’s ruling in place for now, the broader legal battle over the CFPB’s future remains unresolved.
Source: Reuters
Featured News
Federal Appeals Court Temporarily Halts Ruling in Consumer Bureau Battle
Apr 3, 2025 by
CPI
Capital One-Discover $35 Billion Merger Moves Forward After DOJ Decision
Apr 3, 2025 by
CPI
RealPage Sues Berkeley Over Ban on Rental Pricing Software
Apr 3, 2025 by
CPI
Olivia Trusty’s FCC Nomination Set for Senate Hearing Next Week
Apr 3, 2025 by
CPI
Amazon Challenges France’s Book Delivery Fee at EU Court
Apr 3, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition: Year of the Snake
Apr 3, 2025 by
CPI
The Fair Competition Review and the Unified National Market in China
Apr 3, 2025 by
Sen La & Wei Han
Facing the Conundrums: China’s Antitrust Policy Amid Geopolitical Shifts
Apr 3, 2025 by
Da Shi
Concentrations in China in 2023 and 2024
Apr 3, 2025 by
John Yong Ren, Karen Mei & Martha Shu Wen
SAMR’s Evolving Role on the Geopolitical Chessboard
Apr 3, 2025 by
Andrew Foster, Danette Chan & Flora Xiao